Contineum Therapeutics GAAP EPS of -$0.49
Source: SeekingAlpha
2026-03-05 16:33:05 ET
More on Contineum Therapeutics
- Contineum Therapeutics stock drops as company prices upsized $90 million offering
- Contineum Therapeutics announces proposed $75M public offering
- Seeking Alpha’s Quant Rating on Contineum Therapeutics
- Historical earnings data for Contineum Therapeutics
- Financial information for Contineum Therapeutics
Read the full article on Seeking Alpha
For further details see:
Contineum Therapeutics GAAP EPS of -$0.49
Contineum Therapeutics Inc.
NASDAQ: CTNM
CTNM Trading
-0.69% G/L:
$13.755 Last:
93,301 Volume:
$13.80 Open:
CTNM Latest News
March 05, 2026 04:05:00 pm
Contineum Therapeutics Reports Fourth-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones
March 03, 2026 04:05:00 pm
Contineum Therapeutics to Present at the 2026 Leerink Partners Global Healthcare Conference
CTNM Stock Data
$575,338,822
32,401,621
2.76%
10
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
